Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$55,852,860
+$6,408,448 QoQ
Shares Held
3,048,737
-0.2% QoQ
Ownership
0.872%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Derivatives in ERAS
reported options exposure · as of Sep 30, 2022CallValue
$15,600
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ERAS ranks #43 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ERAS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,852,860 | 3,048,737 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $49,444,412 | 3,055,897 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $5,996,080 | 1,611,850 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,344,715 | 1,534,274 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,995,582 | 1,571,325 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,669,889 | 1,948,825 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,883,890 | 1,945,773 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,522,430 | 4,220,671 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,063,234 | 1,721,710 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,531,157 | 2,199,591 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,547,978 | 726,751 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,064,421 | 540,316 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,711,563 | 620,132 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,959,314 | 2,976,517 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,560,867 | 2,682,336 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $15,600 | 2,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $668,669 | 85,727 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $86,328 | 15,499 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $119,315 | 13,874 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $149,162 | 9,574 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $248,804 | 11,725 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||